Zacks: Analysts Anticipate RTI Surgical Inc (RTIX) Will Announce Quarterly Sales of $70.16 Million

Wall Street brokerages forecast that RTI Surgical Inc (NASDAQ:RTIX) will report $70.16 million in sales for the current fiscal quarter, according to Zacks. Two analysts have made estimates for RTI Surgical’s earnings. The highest sales estimate is $70.82 million and the lowest is $69.49 million. RTI Surgical reported sales of $71.35 million in the same quarter last year, which indicates a negative year over year growth rate of 1.7%. The business is scheduled to report its next quarterly earnings report on Thursday, February 22nd.

On average, analysts expect that RTI Surgical will report full-year sales of $70.16 million for the current year, with estimates ranging from $278.40 million to $279.56 million. For the next financial year, analysts anticipate that the firm will report sales of $282.10 million per share, with estimates ranging from $281.94 million to $282.26 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of research analysts that cover RTI Surgical.

RTI Surgical (NASDAQ:RTIX) last announced its quarterly earnings data on Thursday, November 2nd. The medical equipment provider reported $0.01 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.01. The company had revenue of $66.69 million during the quarter, compared to the consensus estimate of $65.63 million. RTI Surgical had a return on equity of 2.29% and a net margin of 1.01%. The firm’s revenue for the quarter was up .2% on a year-over-year basis.

A number of brokerages recently issued reports on RTIX. BidaskClub downgraded RTI Surgical from a “sell” rating to a “strong sell” rating in a research note on Thursday, December 14th. Zacks Investment Research upgraded RTI Surgical from a “sell” rating to a “hold” rating in a research note on Friday, October 13th.

A number of hedge funds have recently bought and sold shares of RTIX. Russell Investments Group Ltd. boosted its stake in RTI Surgical by 12.4% in the 2nd quarter. Russell Investments Group Ltd. now owns 87,742 shares of the medical equipment provider’s stock worth $514,000 after purchasing an additional 9,687 shares during the period. Federated Investors Inc. PA boosted its stake in RTI Surgical by 16.3% in the 2nd quarter. Federated Investors Inc. PA now owns 43,245 shares of the medical equipment provider’s stock worth $253,000 after purchasing an additional 6,065 shares during the period. Alliancebernstein L.P. boosted its stake in RTI Surgical by 11.2% in the 2nd quarter. Alliancebernstein L.P. now owns 65,649 shares of the medical equipment provider’s stock worth $384,000 after purchasing an additional 6,600 shares during the period. AJO LP bought a new position in RTI Surgical in the 2nd quarter worth approximately $2,597,000. Finally, Ameriprise Financial Inc. boosted its stake in RTI Surgical by 91.8% in the 2nd quarter. Ameriprise Financial Inc. now owns 85,937 shares of the medical equipment provider’s stock worth $503,000 after purchasing an additional 41,130 shares during the period. Institutional investors and hedge funds own 69.90% of the company’s stock.

RTI Surgical (RTIX) opened at $4.40 on Tuesday. The stock has a market capitalization of $261.84, a P/E ratio of -62.86, a P/E/G ratio of 1.96 and a beta of 1.76. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.21 and a current ratio of 3.34. RTI Surgical has a 52 week low of $3.01 and a 52 week high of $6.00.

TRADEMARK VIOLATION WARNING: “Zacks: Analysts Anticipate RTI Surgical Inc (RTIX) Will Announce Quarterly Sales of $70.16 Million” was reported by American Banking News and is owned by of American Banking News. If you are reading this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this article can be read at https://www.americanbankingnews.com/2018/01/16/zacks-analysts-anticipate-rti-surgical-inc-rtix-will-announce-quarterly-sales-of-70-16-million.html.

RTI Surgical Company Profile

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Get a free copy of the Zacks research report on RTI Surgical (RTIX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply